Deep Brain Stimulation Market

Deep Brain Stimulation Market Research, 2030

Deep brain stimulation is a surgery that involves implanting a device that transmits a signal to the parts of the brain that control movement. DBS helps to alleviate the symptoms of stiffness, sluggishness, and walking difficulties caused by neurological illnesses such dystonia, Parkinson's disease, and essential tremor. Patients who have not responded to medications for at least five years might consider this treatment. Furthermore, the FDA has authorized this medication for individuals who are unable to undergo epilepsy surgery, which involves separating or removing the region of the brain that causes seizures. As a result, the increased frequency of neurological diseases such as Alzheimer's and Parkinson's disease is a primary driver of market expansion.

Deep Brain Stimulation Market: Key Players

• Abbott (St. Jude Medical)

Company Overview, Business Strategy, Key Product Offerings, Financial Performance, Key Performance Indicators, Risk Analysis, Recent Development, Regional Presence, SWOT Analysis

• Medtronic
• Boston Scientific Corporation
• Aleva Neurotherapeutics S.A.
• Nexstim
• LivaNova PLC
• Neuropace Inc.
• Renishaw PLC
• Beijing PINS Medical Co. Ltd
• Fisher Wallace

Growth Factor

Rapidly aging population

According to the Globe Ageing 2019 study, there were around 703 million people aged 65 and up in the world in 2019. In 2050, this population is expected to increase to 1.5 billion. Furthermore, by 2050, one in every six individuals on the planet will be beyond the age of 65, up from one in every eleven in 2019. The older population is expected to grow, and this group is more susceptible to neurological problems, which will drive the market in the near future.

Segmentation

• By Stimulation Type
  • Subthalamic DBS
  • Globus Pallidus DBS
  • Thalamic DBS
  • Pedunculopontine Nucleus DBS
• By Product
  • Single Channel Deep Brain Stimulator
  • Dual Channel Deep Brain Stimulator
• By Application
  • Parkinson's Disease (PD)
  • Epilepsy
  • Dystonia
  • Obsessive Compulsive Disorder (OCD)
  • Others
• By End-User
  • Hospitals
  • Ambulatory Surgical Centers
  • Neurological Centers
  • Others
• Deep Brain Stimulation Market Dynamics
• Deep Brain Stimulation Market Size
• Supply & Demand
• Current Trends/Issues/Challenges
• Competition & Companies Involved in the Market
• Value Chain of the Market
• Market Drivers and Restraints

Recent News Related to Market

1. In February 2019, Medtronic announced the availability of Deep Brain Simulation (DBS) in the United States for medically resistant epilepsy. Such a unique offering will help the firm expand its consumer base and increase income.

The report sheds light on various aspects and answers pertinent questions on the market. Some of the important ones are:

• COVID-19 pre and post business impact analysis
• Detailed overview of the parent market
• Changing market dynamics in the industry
• In-depth market segmentation

• What is the Deep Brain Stimulation Market growth?
• Which segment accounted for the largest Deep Brain Stimulation Market share?
• Who are the key players in the Deep Brain Stimulation Market?

• Historical, current and projected market size in terms of volume and value
• Recent industry trends and developments
• Competitive landscape
• Strategies of key players and products offered
• Potential and niche segments, geographical regions exhibiting promising growth
• A neutral perspective on market performance
• Must-have information for market players to sustain and enhance their market footprint

Note: Although care has been taken to maintain the highest levels of accuracy in Fatpos Global’s reports, recent market/vendor-specific changes may take time to reflect in the analysis.

Frequently Asked Questions (FAQ):